Literature DB >> 17005056

Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure.

Mahendra Damarla1, Bartolome R Celli, Hana X Mullerova, Victor M Pinto-Plata.   

Abstract

OBJECTIVE: To determine the prevalence of confirmatory use of spirometry in patients admitted to a tertiary-care facility with the diagnosis of chronic obstructive pulmonary disease (COPD), including those with respiratory failure, and compare that to the use of confirmatory 2-dimensional echocardiography (2-D echo) in patients admitted with the diagnosis of congestive heart failure (CHF), to determine preferential confirmatory testing practices.
SETTING: Academic tertiary-care hospital.
METHODS: A 6-month retrospective review of charts of patients with a primary or secondary discharge diagnosis of COPD, respiratory failure, and CHF, using the appropriate International Classification of Diseases, Ninth Revision, Clinical Modification codes. Pulmonary function and echocardiography laboratory databases were reviewed to determine if the patients had had spirometry or 2-D echo performed during the 8 years prior to the study period.
RESULTS: Five hundred fifty-three patients were discharged with the diagnosis of COPD, and 173 patients (31%) had had spirometry. In contrast, 789 patients had the diagnosis of CHF, and a larger proportion of them (619 patients, 78%) had had 2-D echo (p < 0.001). Only 35% of the patients with respiratory failure and COPD had spirometry performed. There were a total of 219 patients with concomitant diagnoses of COPD and CHF. A majority of them (48%) had a 2-D echo as the only confirmatory test, 74 (34%) had both tests performed, 4 (2%) had spirometry only, and 36 (16%) had neither test performed. Of the patients with a diagnosis of COPD who had spirometry, 30% had spirometry findings consistent with restrictive or normal physiology.
CONCLUSIONS: A large proportion of patients hospitalized with the diagnosis of COPD have never had a confirmatory test, including those with presumably advanced disease. Compared to patients with CHF, patients with COPD are less likely to have had the confirmatory test performed, even when both conditions coexist. Many patients with the clinical diagnosis of COPD have an inconsistent physiologic diagnosis. To impact the increasingly important problem of COPD, we must raise awareness of the need to confirm its diagnosis and severity with spirometry.

Entities:  

Mesh:

Year:  2006        PMID: 17005056

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  28 in total

1.  Back to the future: sagittal CT in the evaluation of COPD.

Authors:  Jessica S Hightower; Chiemezie Amadi; Elana Den; James E Schmitt; Rosita M Shah; Wallace T Miller
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

2.  GOLD stage I is not a COPD risk factor.

Authors:  Paul L Enright
Journal:  Thorax       Date:  2007-12       Impact factor: 9.139

3.  Chronic obstructive pulmonary disease after myocardial infarction in the community.

Authors:  Francesca Bursi; Robert Vassallo; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

4.  Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure.

Authors:  Richard Steinacher; John T Parissis; Bernhard Strohmer; Jörg Eichinger; Dennis Rottlaender; Uta C Hoppe; Johann Altenberger
Journal:  Clin Res Cardiol       Date:  2012-03-07       Impact factor: 5.460

5.  Enhancing COPD management in primary care settings.

Authors:  Jill A Foster; Barbara P Yawn; Abdolrasulnia Maziar; Todd Jenkins; Stephen I Rennard; Linda Casebeer
Journal:  MedGenMed       Date:  2007-07-31

6.  Point of Care Portable Spirometry in the Diagnosis and Treatment of Inpatients with Chronic Obstructive Pulmonary Disease.

Authors:  Donald Tran; Melvin Lim; Sara Vogrin; Lata Jayaram
Journal:  Lung       Date:  2020-01-01       Impact factor: 2.584

Review 7.  Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology.

Authors:  Nathaniel Mark Hawkins; Mark C Petrie; Pardeep S Jhund; George W Chalmers; Francis G Dunn; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

8.  Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians.

Authors:  Gregory D Salinas; James C Williamson; Ravi Kalhan; Byron Thomashow; Jodi L Scheckermann; John Walsh; Maziar Abdolrasulnia; Jill A Foster
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-02-28

9.  Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.

Authors:  Eulàlia Borrell; Mar Rodríguez; Pere Torán; Laura Muñoz; Guillem Pera; Núria Montellà; Mònica Monteagudo; Magalí Urrea; Yolanda Puigfel; Antonio Negrete; Xavier Mezquiriz; Cristina Domènech; Anna Lacasta; Ma Llum García; Sandra Maneus; Glòria Tintoré
Journal:  BMC Public Health       Date:  2009-01-09       Impact factor: 3.295

10.  Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation.

Authors:  Daniel E Murphy; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.